| HOME >> MEDICINE >> TECHNOLOGY |
(24,810)(19,921)Net cash used for financing activities
(5,066)(20,082)Net change in cash
(8,427)(28,464)Cash and cash equivalents at beginning of period
35,24263,706Cash and cash equivalents at end of period
$26,815$35,242Summary Balance Sheets INNOPHOS HOLDINGS, INC. AND SUBSIDIARIESCondensed Consolidated Balance Sheets (Unaudited)(Dollars In thousands)December 31,2012December 31,2011ASSETSCurrent assets:Cash and cash equivalents
$26,815$35,242Accounts receivable - trade
94,033104,421Inventories
163,606169,728Other current assets
94,56175,316Total current assets
379,015384,707Property, plant and equipment, net
195,723187,421Goodwill
83,21461,587Intangibles and other assets, net
79,22553,300Total assets
$737,177$687,015LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Current portion of long-term debt
$4,000$4,000Accounts payable, trade and other
36,48532,640Other current liabilities
46,03071,609Total current liabilities
86,515108,249Long-term debt
172,000148,000Other long-term liabilities
34,33937,558Total liabilities
292,854293,807Total stockholders' equity
444,323393,208Total liabilities and stockholders' equity
$737,177$687,015Additional Information
Net debt is a supplemental financial measure that is not required by, or presented in accordance with, USGAAP. The Company believes net debt is helpful in analyzing leverage and as a performance measure for purposes of presentation in this release. The Company defines net debt as total long-term debt (including any current portion) less cash and cash equivalents.
| SOURCE Innophos Holdings, Inc. Copyright©2012 PR Newswire. All rights reserved |